Cover Image
市場調查報告書

青光眼 :主要十大市場的預測 2016-2026年

Glaucoma Forecast in 10 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 355842
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
青光眼 :主要十大市場的預測 2016-2026年 Glaucoma Forecast in 10 Major Markets 2016-2026
出版日期: 2016年04月06日 內容資訊: 英文 48 Pages
簡介

青光眼是帶給視神經損傷的癌症疾病的通稱用語。青光眼主要分為開放性青光眼和隅角閉鎖性青光眼2種。

本報告提供主要十大市場 (美國、法國、德國、義大利、西班牙、英國、日本、印度及中國) 的青光眼的目前患者數 (性別、各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷與預後,主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化患者數的手法

青光眼的最大患病人數

青光眼患者的特徵

  • 青光眼的種類、分類
  • 進行性青光眼的合併症
  • 非進行性青光眼的合併症

簡稱

相關出版

病患人數的線上資料庫

病患人數的產品

價格的線上資料、平台

參考文獻

附錄

目錄
Product Code: GLAU0010416

image1

Glaucoma is a term describing a group of eye disorders that result in optic nerve damage. Glaucoma is divided into two main types: open-angle or closed-angle glaucoma. The condition develops when excess aqueous humour is inadequately drained, causing pressure to build. This may damage the optic nerves and the nerve fibres from the retina. There is a progressive loss of retinal ganglion cells and their axons, and the condition can lead to severe sight impairment.

This report provides the current prevalent population for Glaucoma across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Glaucoma have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Glaucoma include:

  • Diabetes Mellitus
  • Hypertension
  • Dyslipidaemia
  • Myopia
  • Cataracts
  • Intraocular hypertension
  • Alzheimer's disease

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Glaucoma's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Glaucoma and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Glaucoma's prevalent population.
  • Identify sub-populations within Glaucoma which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Glaucoma patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, IN

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Glaucoma

Features of Glaucoma Patients

  • Type and Classification of Glaucoma
  • Progressive Glaucoma Co-morbidities
  • Non-Progressive Glaucoma Co-morbidities

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Tests used for glaucoma diagnosis
  • Prevalence of glaucoma, total (000s)
  • Prevalence of glaucoma, males (000s)
  • Prevalence of glaucoma, females (000s)
  • Type of glaucoma in patients, total (000s)
  • Severity of glaucoma in POAG patients, total (000s)
  • BMI of POAG patients, total (000s)
  • Progressive profile of POAG patients, total (000s)
  • Type of eye involvement in glaucoma patients, total (000s)
  • Prevalence of cataracts in progressive glaucoma patients, total (000s)
  • Prevalence of myopia in progressive glaucoma patients, total (000s)
  • Prevalence of hypertension in progressive glaucoma patients, total (000s)
  • Prevalence of diabetes in progressive glaucoma patients, total (000s)
  • Prevalence of cataracts in non-progressive glaucoma patients, total (000s)
  • Prevalence of myopia in non-progressive glaucoma patients, total (000s)
  • Prevalence of hypertension in non-progressive glaucoma patients, total (000s)
  • Prevalence of diabetes in non-progressive glaucoma patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • USA Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • France Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • France Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • Germany Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • Germany Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • Italy Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • Italy Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • Spain Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • Spain Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • Japan Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • Japan Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • India Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • India Prevalence of Glaucoma by 5-yr age cohort, females (000s)
  • China Prevalence of Glaucoma by 5-yr age cohort, males (000s)
  • China Prevalence of Glaucoma by 5-yr age cohort, females (000s)
Back to Top